Home LiteratureArticle Details
PMID: 7539030 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

A role for C-C chemokines in fibrotic lung disease.

Journal of leukocyte biology ·Vol. 57 ·No. 5 ·1995-05-00 ·Pages 782-7

Smith RE, Strieter RM, Zhang K, Phan SH, Standiford TJ, Lukacs NW, Kunkel SL

Abstract

Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte recruitment and activation, fibroblast proliferation, and increased extracellular matrix production. Previous studies of models of pulmonary fibrosis have investigated the role of cytokines in the evolution of the fibrotic response. The involvement of tumor necrosis factor and interleukin-1 in bleomycin-induced lung injury, a model of idiopathic pulmonary fibrosis, has been well established, suggesting that cytokines mediate the initiation and maintenance of chronic inflammatory lesions. However, the aforementioned cytokines alone cannot account for the recruitment and activation of specific leukocyte populations found in the bleomycin model. Recently, a family of novel proinflammatory cytokines (chemokines) was cloned and characterized, yielding many putative mediators of leukocyte functions. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) and monocyte chemoattractant protein-1 (MCP-1) belong to the C-C chemotactic cytokine family, a group of low-molecular-weight peptides. These molecules modulate chemotaxis, proliferation, and cytokine expression in leukocyte subsets. Our group has investigated the roles of MCP-1 and MIP-1 alpha in the bleomycin model. Both MCP-1 and MIP-1 alpha are expressed in a time-dependent manner after bleomycin challenge, and passive immunization of these animals with either anti-MIP-1 alpha or anti-MCP-1 antibodies attenuated leukocyte accumulation. In addition, we have identified specific cell types expressing MCP-1 or MIP-1 alpha by in situ hybridization and immunohistochemical localization, respectively. Furthermore, our results indicate that MIP-1 alpha expression is mediated by alveolar macrophage-derived tumor necrosis factor, identifying an important cytokine pathway in the initiation of pulmonary fibrosis. Finally, anti-MIP-1 alpha therapy attenuated fibrosis, providing direct evidence for its involvement in fibrotic pathology. Our work has clearly established that the C-C chemokines MCP-1 and MIP-1 alpha are expressed and contribute to the initiation and maintenance of the bleomycin-induced pulmonary lesion.

MeSH Terms
Bleomycin/adverse effects Chemokine CCL4 Chemotactic Factors/physiology Cytokines/physiology Fibroblasts/physiology Humans Lymphocytes/physiology Macrophage Inflammatory Proteins Macrophages/physiology Monocyte Chemoattractant Proteins Monokines/physiology Neutrophils/physiology Pulmonary Fibrosis/physiopathology
Chemicals
Chemokine CCL4 Chemotactic Factors Cytokines Macrophage Inflammatory Proteins Monocyte Chemoattractant Proteins Monokines Bleomycin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Smith R E
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
Strieter R M
Zhang K
Phan S H
Standiford T J
Lukacs N W
Kunkel S L
Article Info
Journal
Journal of leukocyte biology
Abbr.
J Leukoc Biol
ISSN
0741-5400
Published
1995-05-00
Pages
782-7
Language
English
Region
United States
NLM ID
8405628
Subset
IM
Grants
NHLBI NIH HHS · HL02401 · United States
NHLBI NIH HHS · HL28737 · United States
NHLBI NIH HHS · HL31693 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]